Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
65.38 USD | +0.28% | -2.58% | -19.33% |
02:35pm | Redburn Atlantic Adjusts Price Target on Gilead Sciences to $117 From $120 | MT |
Apr. 29 | Barclays Adjusts Price Target on Gilead Sciences to $76 From $80 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.33% | 81.3B | |
+33.31% | 704B | |
+28.33% | 577B | |
-5.35% | 348B | |
+17.77% | 327B | |
+4.11% | 288B | |
+14.92% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.92% | 147B |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- UBS Adjusts Gilead Sciences Price Target to $75 From $81, Maintains Neutral Rating